INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2009

Two follicular lymphoma patients experienced objective tumor regression following the use of Devil's Claw herbal therapy.

Two patients with follicular lymphoma who used Devil's Claw without cytotoxic therapy were evaluated. Patient 1 had stage IIIA lymphoma and showed partial regression on a CT scan 10 months later while taking Devil's Claw and Essiac; this patient later developed overt myeloma and received chemotherapy and stem cell transplantation. Patient 2, also with stage IIIA lymphoma, began Devil's Claw and showed decreased adenopathy and splenomegaly at 11 months, sustained for 4 years. The authors note spontaneous regression occurs in ~16% of lymphoma cases, questioning whether regression was spontaneous or causally related.

Shows an association, not proof of cause and effect.

Study type
Case report (2 patients)
Who was studied
2 patients with follicular lymphoma
What was measured
Tumour regression (lymphadenopathy, splenomegaly)

THE PAPER

Regression of follicular lymphoma with Devil's Claw: coincidence or causation?

Wilson KS. Curr Oncol, 2009.

PubMed 19672427 ↗DOI 10.3747/co.v16i4.401 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.